Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

872668

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Priorities Advisory Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 February to Question 128018, on Clinical Priorities Advisory Group, on what date NHS England plans to announce (a) announce the results of the prioritisation process and (b) make funding available for approved medicines policies.
tabling member constituency	Alyn and Deeside
tabling member printed	Mark Tami
uin	134482
answer	answer is ministerial correction date of answer 04/04/2018 answer text <p>NHS England has advised that it is expected that the recommendations from the relative prioritisation process will be received by the Specialised Services Commissioning Committee (SSCC) meeting on 19 June 2018. The aim will be to communicate the results as soon as possible following the SSCC meeting.</p><p>A process of relative prioritisation for determining discretionary investment in new specialised services was first introduced in 2016/17. Investment decisions are informed following advice from NHS England’s independently chaired Clinical Priorities Advisory Group and against a budget that is fixed annually. In 2016/17 and again in 2017/18, £25 million was set aside for this purpose. This was considered an appropriate level of investment in the context of NHS England’s Specialised Commissioning function having to achieve overall efficiency savings of approximately 2.7% and approximately 2.5% in 2016/17 and 2017/18 respectively in order to meet the financial pressures resulting from demographic growth and the legal requirement to fund all positive National Institute for Health and Care Excellence technology appraisals. Once funding is distributed following this relative prioritisation process, spend is not separately monitored.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 134484 134486 question first answered 04/04/2018 13:20:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1383 label Biography information for Mark Tami

872670

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what process was used to forecast budgetary need in order to determine the £25 million annual budget allocation for products undergoing review by the NHS England specialised commissioning prioritisation process.
tabling member constituency	Alyn and Deeside
tabling member printed	Mark Tami
uin	134484
answer	answer is ministerial correction date of answer 04/04/2018 answer text <p>NHS England has advised that it is expected that the recommendations from the relative prioritisation process will be received by the Specialised Services Commissioning Committee (SSCC) meeting on 19 June 2018. The aim will be to communicate the results as soon as possible following the SSCC meeting.</p><p>A process of relative prioritisation for determining discretionary investment in new specialised services was first introduced in 2016/17. Investment decisions are informed following advice from NHS England’s independently chaired Clinical Priorities Advisory Group and against a budget that is fixed annually. In 2016/17 and again in 2017/18, £25 million was set aside for this purpose. This was considered an appropriate level of investment in the context of NHS England’s Specialised Commissioning function having to achieve overall efficiency savings of approximately 2.7% and approximately 2.5% in 2016/17 and 2017/18 respectively in order to meet the financial pressures resulting from demographic growth and the legal requirement to fund all positive National Institute for Health and Care Excellence technology appraisals. Once funding is distributed following this relative prioritisation process, spend is not separately monitored.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 134482 134486 question first answered 04/04/2018 13:20:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1383 label Biography information for Mark Tami

872672

registered interest
date	27/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the (a) annual budget, (b) total annual expenditure and (c) rationale for how budget allocations were arrived at was for products reviewed by the NHS England specialised commissioning prioritisation process for the last three years for which figures are available.
tabling member constituency	Alyn and Deeside
tabling member printed	Mark Tami
uin	134486
answer	answer is ministerial correction date of answer 04/04/2018 answer text <p>NHS England has advised that it is expected that the recommendations from the relative prioritisation process will be received by the Specialised Services Commissioning Committee (SSCC) meeting on 19 June 2018. The aim will be to communicate the results as soon as possible following the SSCC meeting.</p><p>A process of relative prioritisation for determining discretionary investment in new specialised services was first introduced in 2016/17. Investment decisions are informed following advice from NHS England’s independently chaired Clinical Priorities Advisory Group and against a budget that is fixed annually. In 2016/17 and again in 2017/18, £25 million was set aside for this purpose. This was considered an appropriate level of investment in the context of NHS England’s Specialised Commissioning function having to achieve overall efficiency savings of approximately 2.7% and approximately 2.5% in 2016/17 and 2017/18 respectively in order to meet the financial pressures resulting from demographic growth and the legal requirement to fund all positive National Institute for Health and Care Excellence technology appraisals. Once funding is distributed following this relative prioritisation process, spend is not separately monitored.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 134482 134484 question first answered 04/04/2018 13:20:07 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1383 label Biography information for Mark Tami